Table 1.
Variable | No Adjuvant Chemotherapy (n=811) (%) |
Adjuvant Chemotherapy (n=922) (%) |
p-value |
---|---|---|---|
Age (median [IQR]) | 67(60-75) | 62(55-70) | <0.001 |
Sex (female) | 115(14) | 103(11) | 0.07 |
Race/ethnicity | 0.63 | ||
White | 771(96) | 888(97) | |
Black | 20(3) | 17(2) | |
Other | 11(1) | 11(1) | |
Year of diagnosis | 2007(2006-2010) | 2008(2005-2010) | 0.93 |
Charlson-Deyo score | 0.002 | ||
0 | 533(66) | 657(71) | |
1 | 211(26) | 224(24) | |
≥2 | 67(8) | 41(4) | |
Insurance | <0.001 | ||
Private | 301(38) | 482(53) | |
Government | 484(61) | 417(46) | |
None | 12(1) | 10(1) | |
Academic center | 454(57) | 404(44) | <0.001 |
Pathologic T status | 0.24 | ||
T1 | 178(22) | 173(19) | |
T2 | 172(21) | 182(20) | |
T3 | 446(55) | 549(60) | |
T4 | 15(2) | 18(2) | |
Tumor size (mm) | 38(25-50) | 38(25-55) | 0.49 |
Grade | 0.923 | ||
Low | 24(3) | 29(3) | |
Moderate | 286(37) | 323(36) | |
High | 462(60) | 542(61) | |
Annualized center volume | 6(3-16) | 4(2-10) | <0.001 |
Lymph node ratio (%) | 19(8-40) | 21(10-40) | 0.10 |
Number of nodes examined | 14(9-20) | 15(10-21) | 0.12 |
Number of nodes positive | 2(1-4) | 3(1-5) | 0.001 |
Adjuvant radiation | 80(10) | 650(71) | <0.001 |
Number of radiation treatments | 28(25-30) | 26(25-28) | N/A |
Radiation dose (Gy) | 50.4(45.0-50.4) | 45.0(45.0-50.4) | N/A |
Unplanned 30-day readmission | 70(9) | 50(5) | 0.01 |
Postoperative length of stay | 11(8-18) | 9(7-13) | <0.001 |